Precision editing of gut bacteria reduces cancer in mice
UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.
Aug 1, 2019
0
3
UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.
Aug 1, 2019
0
3
(HealthDay)—There are numerous drugs to treat digestive woes caused by heartburn or stomach ulcers. But solving one health problem may be causing another.
Jul 30, 2019
0
74
New warnings about an increased risk of thrombosis and of death among ulcerative colitis patients taking the 10 mg twice daily dose of the drug tofacitinib (Xeljanz, Xeljanz XR) have been issued by the U.S. Food and Drug ...
Jul 29, 2019
0
3
Inflammatory bowel diseases are chronic, painful disorders of the intestine that afflict roughly 1.5 million people in the United States. Yet the underlying mechanisms of these diseases, which include ulcerative colitis and ...
Jul 26, 2019
0
30
Medical consensus once supported daily use of low dose aspirin to prevent heart attack and stroke in people at increased risk for cardiovascular disease (CVD). But in 2018, three major clinical trials cast doubt on that conventional ...
Jul 23, 2019
0
4
Like doctors around the world, Randy Wolcott was confounded by diabetic foot ulcers.
Jul 15, 2019
0
2
Researchers at Karolinska Institutet in Sweden have found a way of using gene expression conserved across species to divide patients with the inflammatory bowel disease ulcerative colitis into two distinct groups. The findings ...
Jun 28, 2019
0
2
Pressure ulcers are a major burden to patients, carers and the healthcare system. Particularly vulnerable populations are elderly, bedridden and spinal cord injured individuals. Ph.D. researcher Jibbe Soetens investigated ...
Jun 18, 2019
0
0
Inflammation in inflammatory bowel disease (IBD) can be quickly and precisely diagnosed using a new type of nuclear medicine scan, according to research published in the June issue of The Journal of Nuclear Medicine. Using ...
Jun 17, 2019
0
3
The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients ...
Jun 13, 2019
0
2